An open-label, single-arm Phase II study of intravenous weekly (Days 1 and 8) topotecan in combination with carboplatin (Day 1) every 21 days as second-line therapy in patients with platinum-sensitive relapsed ovarian cancer

No Thumbnail Available

Authors

Rose, Peter G.
Monk, Bradley J.
Provencher, Diane
Hartney, Jean
Legenne, Philippe
Lane, Stephen

Issue Date

2011

Volume

120

Issue

1

Type

Journal Article

Language

Keywords

Research Projects

Organizational Units

Journal Issue

Alternative Title

Abstract

Description

Citation

Rose, Peter G.; Monk, Bradley J.; Provencher, Diane; Hartney, Jean; Legenne, Philippe; Lane, Stephen. An open-label, single-arm Phase II study of intravenous weekly (Days 1 and 8) topotecan in combination with carboplatin (Day 1) every 21 days as second-line therapy in patients with platinum-sensitive relapsed ovarian cancer. Gynecologic oncology. 2011, JAN. 120(1):38-42.

Publisher

License

Journal

Volume

Issue

URI

http://hdl.handle.net/10504/60000

PubMed ID

21055798

DOI

Identifier

Additional link

http://cuhsl.creighton.edu/login?url=http://kc7za5wx4c.search.serialssolutions.com/?sid=Refworks%3A&charset=utf-8&__char_set=utf8&genre=article&aulast=Rose&auinit=P.G.&title=Gynecologic%20oncology&stitle=Gynecol.Oncol.&date=2011&volume=120&pages=38-42&issue=1&issn=0090-8258&atitle=An%20open-label%2C%20single-arm%20Phase%20II%20study%20of%20intravenous%20weekly%20(Days%201%20and%208)%20topotecan%20in%20combination%20with%20carboplatin%20(Day%201)%20every%2021%20days%20as%20second-line%20therapy%20in%20patients%20with%20platinum-sensitive%20relapsed%20ovarian%20cancer&spage=38&au=Rose%2CPeter%20G.&au=Monk%2CBradley%20J.&au=Provencher%2CDiane&au=Hartney%2CJean&au=Legenne%2CPhilippe&au=Lane%2CStephen&

ISSN

0090-8258
1095-6859

EISSN

Collections